Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Retraction Note: Distinct Repressive Properties of the Mammalian and Fish Orphan Nuclear Receptors SHP and DAX-1.

Park YY, Teyssier C, Vanacker JM, Choi HS.

Mol Cells. 2018 Dec 31;41(12):1081. doi: 10.14348/molcells.2018.3221. No abstract available.

2.

Design of Boron Nitride/Gelatin Electrospun Nanofibers for Bone Tissue Engineering.

Nagarajan S, Belaid H, Pochat-Bohatier C, Teyssier C, Iatsunskyi I, Coy E, Balme S, Cornu D, Miele P, Kalkura NS, Cavaillès V, Bechelany M.

ACS Appl Mater Interfaces. 2017 Oct 4;9(39):33695-33706. doi: 10.1021/acsami.7b13199. Epub 2017 Sep 21.

PMID:
28891632
3.

A Dominant Mutation in Nuclear Receptor Interacting Protein 1 Causes Urinary Tract Malformations via Dysregulation of Retinoic Acid Signaling.

Vivante A, Mann N, Yonath H, Weiss AC, Getwan M, Kaminski MM, Bohnenpoll T, Teyssier C, Chen J, Shril S, van der Ven AT, Ityel H, Schmidt JM, Widmeier E, Bauer SB, Sanna-Cherchi S, Gharavi AG, Lu W, Magen D, Shukrun R, Lifton RP, Tasic V, Stanescu HC, Cavaillès V, Kleta R, Anikster Y, Dekel B, Kispert A, Lienkamp SS, Hildebrandt F.

J Am Soc Nephrol. 2017 Aug;28(8):2364-2376. doi: 10.1681/ASN.2016060694. Epub 2017 Apr 5.

4.

Heterogeneity in sarcoma cell lines reveals enhanced motility of tetraploid versus diploid cells.

Jemaà M, Abdallah S, Lledo G, Perrot G, Lesluyes T, Teyssier C, Roux P, van Dijk J, Chibon F, Abrieu A, Morin N.

Oncotarget. 2017 Mar 7;8(10):16669-16689. doi: 10.18632/oncotarget.14291.

5.

The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity.

Mas-Y-Mas S, Barbon M, Teyssier C, Déméné H, Carvalho JE, Bird LE, Lebedev A, Fattori J, Schubert M, Dumas C, Bourguet W, le Maire A.

PLoS One. 2016 Nov 3;11(11):e0165139. doi: 10.1371/journal.pone.0165139. eCollection 2016.

6.

The emerging role of the transcriptional coregulator RIP140 in solid tumors.

Lapierre M, Docquier A, Castet-Nicolas A, Gitenay D, Jalaguier S, Teyssier C, Cavaillès V.

Biochim Biophys Acta. 2015 Aug;1856(1):144-50. doi: 10.1016/j.bbcan.2015.06.006. Epub 2015 Jun 25. Review.

PMID:
26116758
7.

An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor β (RARβ, NR1B2) Selective Agonist.

Nadendla E, Teyssier C, Delfosse V, Vivat V, Krishnasamy G, Gronemeyer H, Bourguet W, Germain P.

PLoS One. 2015 May 1;10(5):e0123195. doi: 10.1371/journal.pone.0123195. eCollection 2015.

8.

Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia.

Lapierre M, Castet-Nicolas A, Gitenay D, Jalaguier S, Teyssier C, Bret C, Cartron G, Moreaux J, Cavaillès V.

J Hematol Oncol. 2015 Mar 4;8:20. doi: 10.1186/s13045-015-0116-6. Review.

9.

Transcriptional repression of estrogen receptor α signaling by SENP2 in breast cancer cells.

Nait Achour T, Sentis S, Teyssier C, Philippat A, Lucas A, Corbo L, Cavaillès V, Jalaguier S.

Mol Endocrinol. 2014 Feb;28(2):183-96. doi: 10.1210/me.2013-1376. Epub 2013 Jan 1.

10.

[The Warburg effect: from theory to therapeutic applications in cancer].

Razungles J, Cavaillès V, Jalaguier S, Teyssier C.

Med Sci (Paris). 2013 Nov;29(11):1026-33. doi: 10.1051/medsci/20132911020. Epub 2013 Nov 20. Review. French.

11.

Estrogens repress PGC1-α expression in the uterus.

Macari C, Teyssier C, Tribollet V, Mouzat K, Forcet C, Horard B, Lobaccaro JM, Vanacker JM.

Mol Cell Endocrinol. 2010 Dec 15;330(1-2):33-40. doi: 10.1016/j.mce.2010.08.003. Epub 2010 Sep 9.

PMID:
20816721
12.

A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.

le Maire A, Teyssier C, Erb C, Grimaldi M, Alvarez S, de Lera AR, Balaguer P, Gronemeyer H, Royer CA, Germain P, Bourguet W.

Nat Struct Mol Biol. 2010 Jul;17(7):801-7. doi: 10.1038/nsmb.1855. Epub 2010 Jun 13.

PMID:
20543827
13.

Protein arginine methylation in estrogen signaling and estrogen-related cancers.

Teyssier C, Le Romancer M, Sentis S, Jalaguier S, Corbo L, Cavaillès V.

Trends Endocrinol Metab. 2010 Mar;21(3):181-9. doi: 10.1016/j.tem.2009.11.002. Epub 2009 Dec 11. Review.

14.

Absence of ERRalpha in female mice confers resistance to bone loss induced by age or estrogen-deficiency.

Teyssier C, Gallet M, Rabier B, Monfoulet L, Dine J, Macari C, Espallergues J, Horard B, Giguère V, Cohen-Solal M, Chassande O, Vanacker JM.

PLoS One. 2009 Nov 20;4(11):e7942. doi: 10.1371/journal.pone.0007942.

15.

The orphan receptor ERRalpha interferes with steroid signaling.

Teyssier C, Bianco S, Lanvin O, Vanacker JM.

Nucleic Acids Res. 2008 Sep;36(16):5350-61. doi: 10.1093/nar/gkn520. Epub 2008 Aug 12.

16.

Distinct repressive properties of the mammalian and fish orphan nuclear receptors SHP and DAX-1.

Park YY, Teyssier C, Vanacker JM, Choi HS.

Mol Cells. 2007 Jun 30;23(3):331-9. Retraction in: Mol Cells. 2018 Dec 31;41(12):1081.

18.

Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation.

Teyssier C, Ma H, Emter R, Kralli A, Stallcup MR.

Genes Dev. 2005 Jun 15;19(12):1466-73.

19.

Role of protein methylation in regulation of transcription.

Lee DY, Teyssier C, Strahl BD, Stallcup MR.

Endocr Rev. 2005 Apr;26(2):147-70. Epub 2004 Oct 12. Review.

PMID:
15479858
20.

The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators.

Stallcup MR, Kim JH, Teyssier C, Lee YH, Ma H, Chen D.

J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):139-45. Review.

PMID:
12943698

Supplemental Content

Loading ...
Support Center